UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

The Epidemiology and Consequences of HIV Drug Resistance : Analyses of resistance data from European cohort studies

Schultze, Anna Theresia; (2017) The Epidemiology and Consequences of HIV Drug Resistance : Analyses of resistance data from European cohort studies. Doctoral thesis (Ph.D), UCL (University College London). Green open access

[thumbnail of Schultze_ID_Thesis_FINAL_redacted.pdf]
Preview
Text
Schultze_ID_Thesis_FINAL_redacted.pdf

Download (10MB) | Preview

Abstract

Although the roll-out of effective combination antiretroviral therapy (cART) has brought great benefits, concerns remain regarding the development of drug resistance. This thesis uses data from the EuroSIDA cohort, the UK Collaborative HIV cohort, the UK HIV Drug Resistance Database, the ViroLAB consortium and the EU-Resist collaboration to describe trends in resistance testing, prevalence and incidence as well as the impact of drug resistance on CD4 count declines both in the presence and absence of ART. My findings show that the proportion of people tested for resistance following virological failure in Europe is low (31.6%) and decreasing. Individuals in Eastern Europe were less likely to receive a resistance test (adjusted odds ratio=0.72, 95% confidence interval=0.55-0.94) compared with individuals in Southern Europe. However, among those who were tested, the proportion with resistance was relatively high (77.9%), indicating a potentially selective approach to resistance testing. Among individuals maintained on a failing treatment regimen with resistance to at least one drug class, I found that CD4 counts declined less steeply among individuals with NRTI resistance, the M184V, D67N or T215Y mutation in the reverse transcriptase, or either the V82A or I54V mutation in the protease. In contrast, CD4 counts declined faster among individuals with NNRTI resistance and those with the V179D or L74I reverse transcriptase mutations. A cluster of mutations, including K103N, was also associated with faster CD4 declines. No class of drug resistance or individual mutation had a large impact on the rate of CD4 decline before the start of cART. These findings have implications for public health policy in Europe aimed at minimizing health disparities, and can be used to provide recommendations for the construction of maintenance therapies for individuals with no other treatment options. Further research into HIV drug resistance is imperative to ensure the continued success of cART.

Type: Thesis (Doctoral)
Qualification: Ph.D
Title: The Epidemiology and Consequences of HIV Drug Resistance : Analyses of resistance data from European cohort studies
Event: UCL (University College London)
Open access status: An open access version is available from UCL Discovery
Language: English
Additional information: Third party copyright material has been removed from ethesis.
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health
URI: https://discovery.ucl.ac.uk/id/eprint/10025819
Downloads since deposit
564Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item